Placental Cannabinoid Receptor Expression in Preterm Birth.
J Pregnancy
; 2024: 6620156, 2024.
Article
en En
| MEDLINE
| ID: mdl-38745869
ABSTRACT
Background:
The cannabinoid receptor (CBR) plays a significant role in oogenesis, pregnancy, and childbirth. It might also play a significant role in preterm birth (PTB). The aim of the study was to investigate the association between the expression of the CBR in the placenta and the incidence of PTB.Methods:
This prospective, observational, multicentre preliminary study was conducted on placental samples obtained from 109 women. The study included 95 patients hospitalized due to the high risk of PTB. They were divided into two groups Group 1, where the expression of the CBR1 and CBR1a was analyzed, and Group 2, in which we examined CBR2 expression. The control group, that is, Group 3, consisted of 14 women who delivered at term, and their placentas were tested for the presence of all three receptor types (CBR1, CBR1a, and CBR2).Results:
The study used reverse transcription and real-time PCR methods to assess the expression of CBRs in the placental tissues. The expression of the CBR2, CBR1, and CBR1a receptors was significantly lower in the placentas of women after PTB compared to those after term births, p = 0.038, 0.033, and 0.034, respectively.Conclusions:
The presence of CBR mRNA in the human placental tissue was confirmed. The decreased expression of CBRs could serve as an indicator in predicting PTB.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Placenta
/
Receptor Cannabinoide CB1
/
Receptor Cannabinoide CB2
/
Nacimiento Prematuro
Límite:
Adult
/
Female
/
Humans
/
Pregnancy
Idioma:
En
Año:
2024
Tipo del documento:
Article